Hovione is an international CDMO founded in Portugal in 1959, specialized in helping clients bring new and off-patent drugs to market. The company offers integrated services across multiple drug substance and drug product intermediaries, with a particular expertise in hydrogenation, cryogenic chemistry, corticosteroid chemistry, and particle engineering technologies. With offices and manufacturing sites across the globe, Hovione has a robust international presence. Hovione is also the first chemical/pharmaceutical company to become a Certified B Corp.